Viewing Study NCT01002703


Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2025-12-28 @ 1:07 PM
Study NCT ID: NCT01002703
Status: UNKNOWN
Last Update Posted: 2011-08-12
First Post: 2009-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: University of Leipzig
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module